Laddar...
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Patients with advanced PD may develop potentially disabling motor fluctuations and abnormal involuntary movement (dyskinesia), which cannot be managed with optimized oral or transdermal PD medications. Th...
Sparad:
| I publikationen: | Ther Adv Neurol Disord |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2016
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349373/ https://ncbi.nlm.nih.gov/pubmed/28344656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616681280 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|